View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/CMS RIN: 0938-AP77 Publication ID: Spring 2010 
Title: Revisions to the Medicare Advantage and Medicare Prescription Drug Benefit Programs for Contract Year 2011 (CMS-4085-F) 
Abstract: This final rule makes revisions to the regulations governing the Medicare Advantage (MA) program (Part C) and prescription drug benefit program (Part D) based on our continued experience in the administration of the Part C and D programs. The revisions strengthen various program participation and exit requirements; strengthen beneficiary protections; ensure that plan offerings to beneficiaries include meaningful differences; improve plan payment rules and processes; improve data collection for oversight and quality assessment; implement new policy such as a Part D formulary policy; and clarify program policy. 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: Yes  Unfunded Mandates: Private Sector 
EO 13771 Designation: uncollected 
CFR Citation: 42 CFR 417    42 CFR 422 and 423    42 CFR 480   
Legal Authority: MMA 2003    MIPPA (title XVIII of the Social Security Act)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  10/22/2009  74 FR 54634   
NPRM Comment Period End  12/07/2009    
Final Action  10/00/2012    
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: State 
Small Entities Affected: Organizations  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: Yes 
Agency Contact:
Alissa Deboy
Director, Division of Drug Plan Policy and Quality
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Mail Stop C1-26-26, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-6041
Email: alissa.deboy@cms.hhs.gov